|
Industry Praises MDUFMA Progress, FDA Frets About Meeting Deadline
The device industry and the FDA are closer to an agreement on reauthorizing the Medical Device User Fee Amendments Act (MDUFMA), but chances are slim that the agency will meet the Jan. 15 goal to delivery that agreement to Congress.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives